INSIGHTS ON DRUG DEVELOPMENT

DRUG DEVELOPMENT SOLUTIONS

  • MabSelect™ VL affinity resin uses a protein L ligand with strong affinity for the variable region of a human antibody’s kappa light chain. The resin offers high productivity and robust processes for affinity capture of bispecific antibodies and antibody fragments containing the kappa light chain and offers a good capture alternative for antibody variants that does not bind to protein A.

  • Orbis provides innovative taste-making and controlled release solutions for oral and injectable pharmaceutical products.

  • Explore the design services offered by the Gibco Media by Design team including cell line development, media and feed panel evaluations, bioproduction analytics and more.

  • Upperton have developed UpperNose™, a nasal product development approach designed to streamline the development process for nasal dosage forms.

  • MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.